Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.

Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.

Item
http://www.wikidata.org/entity/Q44948618
Recent advances in oral vaccine development: yeast-derived β-glucan particlesOral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?Microemulsions for oral administration and their therapeutic applicationsPharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticlesEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltNano composite emulsion for sustained drug release and improved bioavailability.Development and validation of a HPLC method for the determination of cyclosporine a in new bioadhesive nanoparticles for oral administrationUnderstanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
P2860

Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.

Item
http://www.wikidata.org/entity/Q44948618
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Bioavailability and pharmacoki ...... icles for oral administration.
@en
Bioavailability and pharmacoki ...... icles for oral administration.
@nl
type
label
Bioavailability and pharmacoki ...... icles for oral administration.
@en
Bioavailability and pharmacoki ...... icles for oral administration.
@nl
prefLabel
Bioavailability and pharmacoki ...... icles for oral administration.
@en
Bioavailability and pharmacoki ...... icles for oral administration.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Bioavailability and pharmacoki ...... icles for oral administration.
@en
P2093
P304
P31
P356
10.1016/J.JCONREL.2004.03.003
P407
P433
P478
P577
P698
P921